Literature DB >> 14986775

Placebo and the Helsinki Declaration--what to do?

Bozidar Vrhovac1.   

Abstract

The Helsinki Declaration is the 'gold standard'--a directive, not a law, on how to conduct controlled studies in humans in conformity with ethical principles. In spite of many discussions about their unsuitability some articles have remained unchanged in the most recent (sixth) revision of the Declaration. The demand to use "the best treatment" excludes use of placebo in the control group and presents an obstacle to the scientific evaluation of a number of drugs and treatments in general. The use of placebo is justified whenever its use does not cause irreversible damage or considerable suffering to the well informed patient. It must be, is, and will be used in the controlled clinical trials of treatments of a great number of diseases especially those which have a tendency to spontaneous improvement, even healing, or have a pronounced psychological component.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Substances:

Year:  2004        PMID: 14986775     DOI: 10.1007/s11948-004-0066-9

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  16 in total

1.  Placebo-controlled trials and the Declaration of Helsinki.

Authors:  John A Lewis; Bertil Jonsson; Gottfried Kreutz; Cristina Sampaio; Barbara van Zwieten-Boot
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

2.  Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.

Authors:  S S Ellenberg; R Temple
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

3.  Is placebo surgery unethical?

Authors:  Sam Horng; Franklin G Miller
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

4.  Unnecessary holes in the head.

Authors:  G R Gillett
Journal:  IRB       Date:  2001 Nov-Dec

5.  The continuing unethical use of placebo controls.

Authors:  K J Rothman; K B Michels
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245

6.  Placebos and controlled trials under attack.

Authors:  L Lasagna
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

Review 7.  The rationale and ethics of medication-free research in schizophrenia.

Authors:  W T Carpenter; N R Schooler; J M Kane
Journal:  Arch Gen Psychiatry       Date:  1997-05

8.  The revised Declaration of Helsinki--is justice served?

Authors:  J C Diamant
Journal:  Int J Clin Pharmacol Ther       Date:  2002-02       Impact factor: 1.366

9.  A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.

Authors: 
Journal:  Sleep       Date:  2002-02-01       Impact factor: 5.849

10.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

View more
  2 in total

Review 1.  Maintenance of Blinding in Clinical Trials and the Implications for Studying Analgesia Using Cannabinoids.

Authors:  Barth Wilsey; Reena Deutsch; Thomas D Marcotte
Journal:  Cannabis Cannabinoid Res       Date:  2016-07-01

Review 2.  Placebo: its action and place in health research today--summary and conclusions.

Authors:  Raymond E Spier
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.